Cite
HARVARD Citation
Zhou, H. et al. (2020). Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy. Journal of cachexia, sarcopenia and muscle. 11 (3), pp. 768-782. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhou, H. et al. (2020). Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy. Journal of cachexia, sarcopenia and muscle. 11 (3), pp. 768-782. [Online].